Allison Wey

Allison Wey currently works at Xeris Biopharma Holdings, Inc., as SVP-Investor Relations & Corporate Communications.
Ms. Wey also formerly worked at Bear, Stearns & Co., Inc., as Associate Director-Equity Capital Markets from 1986 to 1997, Endo Generics Holdings, Inc., as Senior Director-Investor Relations in 2010, Hill & Knowlton, Inc., as Managing Director-Financial Communications from 1997 to 1998, Boron, LePore & Associates, Inc., as VP-Investor Relations & Corporate Affairs from 1999 to 2002, Xeris Pharmaceuticals, Inc., as SVP-Investor Relations & Communications, Edelman Financial Services LLC, as Senior Vice President-Worldwide from 1998 to 1999, Edge Therapeutics, Inc., as Investor Relations Contact, Par Pharmaceutical, Inc., as VP-Investor Relations & Corporate Communications from 2007 to 2012, Regulus Therapeutics, Inc., as VP-Investor Relations & Corporate Communications from 2016 to 2018, Durata Therapeutics, Inc., as VP-Investor Relations & Corporate Communications from 2012 to 2015, and Lepore Associates LLC, as Vice President-Investor Relations.
Ms. Wey received her undergraduate degree from Drake University.